Skip to content

Scholar Rock SRRK Total Assets

Total Assets at other companies

Biogen logo
BiogenBIIB
$29.48B+5.2%
Edgewise Therapeutics, Inc. logo
Edgewise Therapeutics, Inc.EWTX
$518.52M+14.1%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$2.87B+8.0%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$1.08B+49.8%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$1.15B+26.3%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$903.01M+218%

Other financials

Income statement

See full
Revenue-
Operating income-$102.0M-32.3%
Net income-$105.5M-41.2%
EPS (diluted)-$0.83-23.9%

Balance sheet

See full
Cash & equivalents$430.5M+212%
Total debt$205.7M+226%
Total equity$276.0M-11.6%

Cash flow

See full
Operating cash flow-$82.1M-4.4%
CapEx$68.0K-74.9%
Free cash flow-$82.2M-4.1%

Valuation

See full
Market cap$5.67B+85.5%

Profitability

See full
Operating margin-231.8%
Net margin-236.9%
FCF margin-309.1%

Returns & leverage

See full
Return on equity-138.9%+60.1pp
Debt / equity0.7×+0.5×
Current ratio8.6×-1.6×

Where this comes from

Reported directly by Scholar Rock in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Scholar Rock’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scholar Rock's total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scholar Rock's total assets?
Scholar Rock (SRRK) reported total assets of $535.25M in Q1 2026.
How has Scholar Rock's total assets changed year-over-year?
Scholar Rock's total assets increased by 31.3% year-over-year, from $407.55M to $535.25M.
What is the long-term trend for Scholar Rock's total assets?
Over 5 years (2020 to 2025), Scholar Rock's total assets has grown at a 0.8% compound annual growth rate (CAGR), from $388.31M to $404.27M.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.